The Supreme Court is weighing a set of cases that could determine whether manufacturers of glyphosate-based herbicides like Roundup can be held liable under state law for cancer-related harms, even when the EPA has approved the product's labeling. The cases have drawn significant attention from public health advocates, agricultural interests, and legal experts across the political spectrum.
At the center of the litigation is glyphosate, the world's most widely used herbicide, which Bayer sells under the Roundup brand. Thousands of plaintiffs have sued claiming exposure to the weedkiller caused their non-Hodgkin's lymphoma. Bayer argues that because the EPA has reviewed and approved Roundup's label — which does not include a cancer warning — state-court jury verdicts requiring such warnings are preempted by federal law.
The Supreme Court's decision could have sweeping consequences: a ruling for Bayer would effectively insulate the company from billions of dollars in jury awards, while a ruling for plaintiffs could expose pesticide and chemical manufacturers broadly to state-level liability even when federal regulators have signed off on their products. The EPA has maintained that glyphosate is unlikely to be carcinogenic to humans when used as directed, a position contested by some international health bodies.
The cases reached the high court amid a broader political controversy over pesticide regulation. During a recent congressional hearing, a heated exchange between EPA Administrator Lee Zeldin and a Democratic lawmaker drew widespread coverage, with Zeldin pushing back sharply after a suggestion he drink the herbicide. The confrontation underscored the charged atmosphere surrounding both pesticide oversight and the MAHA — Make America Healthy Again — initiative's scrutiny of chemicals in food and agriculture.
The Supreme Court's eventual ruling is expected to clarify the boundaries of federal preemption in product liability cases, with implications extending well beyond glyphosate to the broader landscape of federally regulated consumer and agricultural products.
Left-Leaning Emphasis
- The Guardian frames the case primarily around public health risks and the potential for corporate immunity from accountability for cancer-causing products.
- NPR highlights the intersection of the MAHA initiative and pesticide policy, questioning whether the Trump administration's health agenda is consistent with its EPA stance on glyphosate.
- PBS NewsHour emphasizes the unresolved scientific debate over glyphosate's health risks and gives weight to concerns raised by plaintiffs and health advocates.
Right-Leaning Emphasis
- The New York Post focuses on EPA Administrator Zeldin's forceful response to a Democratic lawmaker, framing the exchange as a political overreach by the Democrat.
- Breitbart centers its coverage on Rep. Rosa DeLauro's conduct during the hearing, portraying her as having embarrassed herself and Democrats with the confrontation.
- Both right-leaning outlets treat the congressional hearing as the primary news hook rather than the Supreme Court case or public health dimensions.